4Q Revenues: $1.5 billion (+8%)
4Q Earnings: $108.1 million (earnings were $88,444 4Q14)
FY Revenues: $5.7 billion (+5%)
FY Earnings: $388.3 million (+9%)
Comments: Product Development revenues were $845.7 million in the quarter, up 9% but negatively impacted by $22.4 million from unfavorable foreign exchange. The Integrated Healthcare Services revenues were $282.9 million, down 2%, negatively impacted by $13.1 million from unfavorable foreign exchange. New business of $1.49 billion was recorded in the quarter, representing a book-to-bill ratio of 1.32.